Innovative health IT tools like those developed by Carevive help maximize the balance between patient self-management and care team engagement, which is especially important in the era of value-based care, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
Innovative health IT tools like those developed by Carevive help maximize the balance between patient self-management and care team engagement, which is especially important in the era of value-based care, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
Transcript (slightly modified)
How does Carevive use health IT to develop innovative solutions for cancer care providers?
Carevive’s approach to innovative solutions in cancer care is to develop tools that help maximize that balance between patient self-management and care team engagement across the care continuum. So as we are rapidly moving into this era of value-based care, where cancer care teams are going to be held accountable to patient outcomes and costs, engaging the patient in their own care has been shown again and again in a number of studies to improve not only patient outcomes but also decrease cost. And so we need to get that piece of the puzzle right, but we need to also ensure that the care teams know when to engage with the patient, when that patient is at risk, when they’re moving outside that area of being able to manage their own healthcare.
So we do that through innovative solutions that in a validated and highly tailored fashion ask patients about their symptoms, their functional status, their concerns, their goals for their care and their quality of life throughout their cancer experience, and then give them the tools they need to self-manage symptoms as they’re starting to progress. To know when to call the care team as symptoms, function, and other issues are worsening, and then to engage the entire care team—not just the physician or the nurse or the advanced practice provider in the clinical visit at the point of care where you’ve got that 15 minute, at most, visit.
We also have the tools to ensure that those patients who are running into trouble between visits get the attention from the care team that they need, by actively alerting those care providers.
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More
Implementation, Adherence to DoxyPEP Remains Low in At-Risk Groups
March 12th 2025Patients in Washington D.C. and San Francisco had minimal early uptake and adherence to doxycycline post-exposure prophylaxis (DoxyPEP) in studies presented at the Conference on Retroviruses and Opportunistic Infections 2025.
Read More